Royalty Pharma
RPRX
#620
Rank
C$56.47 B
Marketcap
C$98.22
Share price
-0.01%
Change (1 day)
77.98%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): C$2.13

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is C$2.19. In 2025 the company made an earnings per share (EPS) of C$2.56 a decrease over its 2024 EPS that were of C$2.75.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$2.13-16.87%
2025C$2.56-7.1%
2024C$2.75
2020C$2.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
C$3.87 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.18 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$7.41 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA